In Vivo Dosimetry During Prostate Cancer Radiotherapy



Status:Completed
Conditions:Prostate Cancer
Therapuetic Areas:Oncology
Healthy:No
Age Range:18 - Any
Updated:4/21/2016
Start Date:November 2011
End Date:September 2015

Use our guide to learn which trials are right for you!

Pilot Study to Evaluate In Vivo Plastic Scintillation Detectors for Real-Time Radiation Dosimetry During Prostate Cancer Radiotherapy

The goal of this clinical research study is to learn if a rectal balloon with attached
radiation detectors can be used to help researchers monitor the dose of external beam
radiation that is delivered to the prostate during treatment. This may help researchers
better understand the side effects of radiation therapy, such as rectal bleeding, and may
lead to changes in treatment planning or treatment delivery.

As a part of your standard of care, you will have external beam radiation therapy. You will
have a computerized tomography (CT) scan of the pelvis before the external beam radiation
therapy.

For the CT scan, you will be given an enema to empty your bowel, and you will drink about 16
to 24 ounces of water to fill your bladder

A rectal balloon will then be inserted into your rectum and filled with either air or water.
You will then have the CT scan. The CT scan should take about 45 minutes.

If you agree to take part in this study, very thin (millimeter-sized) radiation detectors
will be attached to the rectal balloon during each of two CT scans per week you will have
while you are receiving radiation. You may have additional CT scans (without the detector)
each week if your doctor thinks it is needed.

The doses read by the radiation detectors will be compared to the doses that you were
originally scheduled to receive after each radiation treatment and at the end of the study.

You will be off study after your final radiation treatment using the rectal balloon.

This is an investigational study. Up to 15 patients will take part in this study. All will
be enrolled at MD Anderson.

Inclusion Criteria:

1. Any patients with prostate cancer who are undergoing routine radiation therapy for
their prostate cancer, including post-prostatectomy patients.

2. The selection criteria will be limited to the patient's ability to withstand
insertion of a rectal balloon and his willingness to participate in the study.

3. We will choose patients undergoing photon and proton treatments.

Exclusion Criteria:
We found this trial at
1
site
1515 Holcombe Blvd
Houston, Texas 77030
 713-792-2121
University of Texas M.D. Anderson Cancer Center The mission of The University of Texas MD...
?
mi
from
Houston, TX
Click here to add this to my saved trials